Serum level of Interleukin 12 in patients with multiple sclerosis
Int J Neurosci
.
2019 Feb;129(2):207-208.
doi: 10.1080/00207454.2018.1504782.
Epub 2018 Oct 31.
Authors
Hamidreza Jahanbani-Ardakani
1
,
Fereshteh Alsahebfosoul
2
,
Saeed-Reza Moshfeghi
3
,
Behzad Mahaki
4
,
Masoud Etemadifar
5
,
Seyed-Hossein Abtahi
6
,
Mahboobeh Fereidan-Esfahani
7
Affiliations
1
a Isfahan Medical Students Research Center (IMSRC) , Isfahan University of Medical Sciences , Isfahan , Iran.
2
b Department of Immunology, Faculty of Medicine , Isfahan University of Medical Sciences , Isfahan , Iran.
3
c Department of Immunology, Faculty of Medicine , Isfahan University of Medical Sciences , Isfahan , Iran.
4
d Department of Biostatistics, School of Public Health , Isfahan University of Medical Sciences , Isfahan , Iran.
5
e Department of Neurology, Faculty of Medicine , Isfahan University of Medical Sciences , Isfahan , Iran.
6
f Department of Immunology, Faculty of Medicine , Isfahan University of Medical Sciences , Isfahan , Iran.
7
g Department of Neurology , Mayo Clinic , Rochester, New York , USA.
PMID:
30086672
DOI:
10.1080/00207454.2018.1504782
No abstract available
Publication types
Letter
MeSH terms
Adult
Female
Humans
Interleukin-12 Subunit p35 / blood*
Iran
Male
Multiple Sclerosis, Relapsing-Remitting / blood*
Substances
IL12A protein, human
Interleukin-12 Subunit p35